mTORC1 and SIRT1 Cooperate to Foster Expansion of Gut Adult Stem Cells during Calorie Restriction
This personalized approach ensures that the therapy is tailored to deliver the best possible outcomes
While some foods and supplements may have mild blood-thinning effects, they cannot replace prescription anticoagulants
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently unapproved by the MHRA, EMA, or FDA for routine clinical use
Considering this, this article reviews the pharmacokinetics of SS-31, its possible molecular mechanisms in the treatment of renal diseases, and relevant preclinical and clinical studies on SS-31, and finally discusses its potential targets in the treatment of renal diseases, with the aim developing a new management path in the renal field